Amyloidosis and Alzheimer's disease
- PMID: 12453671
- DOI: 10.1016/s0169-409x(02)00149-7
Amyloidosis and Alzheimer's disease
Abstract
Alzheimer's disease (AD) is the most frequent type of amyloidosis in humans and the commonest form of dementia. Extracellular Abeta amyloid deposits in the form of amyloid plaques and cerebral amyloid angiopathy as well as intraneuronal neurofibrillary tangles co-exist in the brain parenchyma of AD patients, the cognitive areas being the most severely affected. This review focuses on the potential role of amyloid in the development of neurodegeneration and presents studies of AD and other unrelated inherited dementia syndromes associated with neuronal loss and amyloid deposition in the brain.
Copyright 2002 Elsevier Science B.V.
Similar articles
-
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.Am J Pathol. 1987 Dec;129(3):422-8. Am J Pathol. 1987. PMID: 3322021 Free PMC article.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
-
Preamyloid lesions and cerebrovascular deposits in the mechanism of dementia: lessons from non-beta-amyloid cerebral amyloidosis.Neurodegener Dis. 2008;5(3-4):173-5. doi: 10.1159/000113694. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322382 Free PMC article. Review.
-
Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein.Nature. 1991 Dec 12;354(6353):476-8. doi: 10.1038/354476a0. Nature. 1991. Retraction in: Nature. 1992 Mar 5;356(6364):23. doi: 10.1038/356023b0. Retraction in: Nature. 1992 Mar 19;356(6366):265. doi: 10.1038/356265a0. PMID: 1793460 Retracted.
-
Vascular Amyloidosis in Neurodegenerative Conditions.Drug News Perspect. 2002 Sep;15(7):439-444. doi: 10.1358/dnp.2002.15.7.840079. Drug News Perspect. 2002. PMID: 12677179
Cited by
-
Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a011452. doi: 10.1101/cshperspect.a011452. Cold Spring Harb Perspect Med. 2012. PMID: 23028132 Free PMC article. Review.
-
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity.Front Cell Dev Biol. 2022 Feb 2;9:809952. doi: 10.3389/fcell.2021.809952. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35186957 Free PMC article. Review.
-
γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processing.J Cell Mol Med. 2022 Feb;26(3):880-892. doi: 10.1111/jcmm.17146. Epub 2021 Dec 20. J Cell Mol Med. 2022. PMID: 34931449 Free PMC article.
-
Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease.Front Pharmacol. 2022 Jun 28;13:924429. doi: 10.3389/fphar.2022.924429. eCollection 2022. Front Pharmacol. 2022. PMID: 35837291 Free PMC article. Review.
-
Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.J Alzheimers Dis. 2014;42 Suppl 3(0 3):S167-76. doi: 10.3233/JAD-140027. J Alzheimers Dis. 2014. PMID: 24670400 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical